PRABHJOT AUJLA: Open Payments
NPI 1659949659 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 23 payments from 13 companies in 2025. Trend: 2023 $675 · 2024 $811 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $142 |
| ViiV Healthcare Company | 2 | $126 |
| Gilead Sciences, Inc. | 2 | $113 |
| AstraZeneca Pharmaceuticals LP | 1 | $64 |
| Dexcom, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Organon LLC | 1 | $29 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: APRETUDE, Descovy, BREZTRI, Rybelsus, Wegovy, Dexcom G6 Transmitter, Ozempic, FLUZONE HIGH-DOSE.
Industry payments across CA — which companies pay providers there.
